1. Home
  2. BJDX

as of 12-04-2025 3:22pm EST

$1.21
+$0.07
+6.14%
Stocks Health Care Medical Specialities Nasdaq

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Chart Type:
Time Range:
Founded: 2015 Country:
United States
United States
Employees: N/A City: ACTON
Market Cap: 2.4M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 78.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -6.78 EPS Growth: N/A
52 Week Low/High: $1.13 - $10.20 Next Earning Date: 11-07-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 55.56%

AI-Powered BJDX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 73.65%
73.65%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: